Nalaganje...
Biosimilar insulins: guidance for data interpretation by clinicians and users
Biosimilar insulins are approved copies of insulins outside patent protection. Advantages may include greater market competition and potential cost reduction, but clinicians and users lack a clear perspective on ‘biosimilarity’ for insulins. The manufacturing processes for biosimilar insulins are ma...
Shranjeno v:
| izdano v: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Blackwell Publishing Ltd
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744724/ https://ncbi.nlm.nih.gov/pubmed/25974131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12491 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|